Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma

被引:0
|
作者
Arevalo-Perez, Julio [1 ,2 ]
Trang, Andy [1 ]
Yllera-Contreras, Elena [1 ]
Yildirim, Onur [1 ,2 ]
Saha, Atin [1 ,2 ]
Young, Robert [1 ,2 ,3 ]
Lyo, John [1 ,2 ]
Peck, Kyung K. [1 ,4 ]
Holodny, Andrei I. [1 ,2 ,3 ,5 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10065 USA
[2] Cornell Univ, Weill Med Coll, Dept Radiol, 525 East 68th St, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, 1275 York Ave, New York, NY 10065 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med Phys, 1275 York Ave, New York, NY 10065 USA
[5] Weill Cornell Grad Sch Med Sci, Dept Neurosci, 1300 York Ave, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
dynamic contrast-enhanced (DCE) perfusion MRI; maximum plasma volume Vp max; Ktrans; GBM; progression of disease; POD; APPARENT DIFFUSION-COEFFICIENT; PERFUSION MRI; PARAMETERS; TUMOR; RADIOTHERAPY; VOLUME;
D O I
10.3390/cancers16101839
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Purpose: Distinguishing treatment-induced imaging changes from progressive disease has important implications for avoiding inappropriate discontinuation of a treatment. Our goal in this study is to evaluate the utility of dynamic contrast-enhanced (DCE) perfusion MRI as a biomarker for the early detection of progression. We hypothesize that DCE-MRI may have the potential as an early predictor for the progression of disease in GBM patients when compared to the current standard of conventional MRI. Methods: We identified 26 patients from 2011 to 2023 with newly diagnosed primary glioblastoma by histopathology and gross or subtotal resection of the tumor. Then, we classified them into two groups: patients with progression of disease (POD) confirmed by pathology or change in chemotherapy and patients with stable disease without evidence of progression or need for therapy change. Finally, at least three DCE-MRI scans were performed prior to POD for the progression cohort, and three consecutive DCE-MRI scans were performed for those with stable disease. The volume of interest (VOI) was delineated by a neuroradiologist to measure the maximum values for Ktrans and plasma volume (Vp). A Friedman test was conducted to evaluate the statistical significance of the parameter changes between scans. Results: The mean interval between subsequent scans was 57.94 days, with POD-1 representing the first scan prior to POD and POD-3 representing the third scan. The normalized maximum Vp values for POD-3, POD-2, and POD-1 are 1.40, 1.86, and 3.24, respectively (FS = 18.00, p = 0.0001). It demonstrates that Vp max values are progressively increasing in the three scans prior to POD when measured by routine MRI scans. The normalized maximum Ktrans values for POD-1, POD-2, and POD-3 are 0.51, 0.09, and 0.51, respectively (FS = 1.13, p < 0.57). Conclusions: Our analysis of the longitudinal scans leading up to POD significantly correlated with increasing plasma volume (Vp). A longitudinal study for tumor perfusion change demonstrated that DCE perfusion could be utilized as an early predictor of tumor progression.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma
    Allison F. O’Neill
    Lei Qin
    Patrick Y. Wen
    John F. de Groot
    Annick D. Van den Abbeele
    Jeffrey T. Yap
    [J]. Journal of Neuro-Oncology, 2016, 130 : 495 - 503
  • [2] Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma
    O'Neill, Allison F.
    Qin, Lei
    Wen, Patrick Y.
    de Groot, John F.
    Van den Abbeele, Annick D.
    Yap, Jeffrey T.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2016, 130 (03) : 495 - 503
  • [3] Analysis of DCE-MRI for Early Prediction of Breast Cancer Therapy Response
    Machireddy, Archana
    Thibault, Guillaume
    Huang, Wei
    Song, Xubo
    [J]. 2018 40TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2018, : 682 - 685
  • [4] Investigation of Longitudinal Salivary Gland DCE-MRI Changes
    Ger, R.
    Awan, M.
    Mohamed, A.
    Ding, Y.
    Frank, S.
    Howell, R.
    Li, H.
    Liu, H.
    Mohan, R.
    Schellingerhout, D.
    Stafford, R.
    Wang, J.
    Fuller, C.
    Court, L.
    [J]. MEDICAL PHYSICS, 2016, 43 (06) : 3829 - 3829
  • [5] DCE-MRI for Early Prediction of Response in Hepatocellular Carcinoma after TACE and Sorafenib Therapy: A Pilot Study
    Saito, Kazuhiro
    Ledsam, Joseph
    Sugimoto, Katsutoshi
    Sourbron, Steven
    Araki, Yoichi
    Tokuuye, Koichi
    [J]. JOURNAL OF THE BELGIAN SOCIETY OF RADIOLOGY, 2018, 102 (01)
  • [6] CONVEX ANALYSIS FOR SEPARATION OF FUNCTIONAL PATTERNS IN DCE-MRI: A LONGITUDINAL STUDY TO ANTIANGIOGENIC THERAPY
    Chan, Tsung-Han
    Chen, Li
    Choyke, Peter L.
    Chi, Chong-Yung
    Wang, Yue
    [J]. 2008 IEEE WORKSHOP ON MACHINE LEARNING FOR SIGNAL PROCESSING, 2008, : 261 - +
  • [7] DCE-MRI Texture Features for Early Prediction of Breast Cancer Therapy Response
    Thibault, Guillaume
    Tudorica, Alina
    Afzal, Aneela
    Chui, Stephen Y-C
    Naik, Arpana
    Troxell, Megan L.
    Kemmer, Kathleen A.
    Oh, Karen Y.
    Roy, Nicole
    Jafarian, Neda
    Holtorf, Megan L.
    Huang, Wei
    Song, Xubo
    [J]. TOMOGRAPHY, 2017, 3 (01) : 23 - 32
  • [8] The earlier evaluation of response to neoadjuvant chemoradiation therapy in sarcoma using DCE-MRI
    Kuang, Y.
    Xia, W.
    Chen, L.
    Gao, X.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S870 - S871
  • [9] In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats
    Julie Bolcaen
    Benedicte Descamps
    Marjan Acou
    Karel Deblaere
    Caroline Van den Broecke
    Tom Boterberg
    Christian Vanhove
    Ingeborg Goethals
    [J]. Molecular Imaging and Biology, 2017, 19 : 857 - 866
  • [10] In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats
    Bolcaen, Julie
    Descamps, Benedicte
    Acou, Marjan
    Deblaere, Karel
    Van den Broecke, Caroline
    Boterberg, Tom
    Vanhove, Christian
    Goethals, Ingeborg
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2017, 19 (06) : 857 - 866